NEW YORK, Sept. 14, 2017 -- Solar Senior Capital Ltd. (the “Company”) (NASDAQ:SUNS) today declared a distribution of $0.1175 per share for the month of September 2017. The distribution is payable on October 3, 2017 to stockholders of record as of September 22, 2017. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year.
ABOUT SOLAR SENIOR CAPITAL LTD.
Solar Senior Capital Ltd. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. The Company invests primarily in leveraged, middle market companies in the form of senior secured loans including first lien and second lien debt instruments.
FORWARD-LOOKING STATEMENTS
Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Solar Senior Capital Ltd. undertakes no duty to update any forward-looking statements made herein.
Contact:
Solar Senior Capital Ltd.
Investor Relations
646-308-8770


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



